colorectal cancer
Conditions
Interventions
Sponsors
Watanabe Jun
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients over 18 years old age 2. Histologically, diagnosed with colorectal cancer 3. Preoperative diagnosis of curative primary resection 4. D2 or higher lymph node dissection is pre-planned 5. Clinical stage I to IIIC (T1-4b, N0-2b, M0: TNMClassification) has been diagnosed 6. Patients who are diagnosed out of the endoscopic resection 7. Patients with tumor maximum diameter of 8 cmor less 8. Patients who do not recognize multiple lesions that require two or more anastomosis places 9. Patients with ECOG Performance Status (PS) score of 0 to 2 10. Patients who have the judgment to fully understand the research content. 11. Patients with written informed consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with chemotherapy (systemic anti-cancer drug treatment) and a history of radiation therapy, including treatment for other cancer species. 2. Patients planning combined resection of other organs due to infiltration of other organs. 3. Patients who have a history of open surgery 4. Patients who have a history of laparoscopic stomach resection or colectomy 5. Patients with the latest check values within 28 days before registration meet the following Leukocyte 100 IU / L, ALT> 100 IU / L, Serum Cr> 1.5 mg / dl. 6. Patients planning simultaneous resection of other organs due to double cancer. 7. Patients with serious complications. 8. Other patients who are judged to be unsuitable as a subject by the doctor's judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative complications within 30 days after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Conversion rate 2. Readmission rate within 30 days after surgery 3. Mortality rate within 30 days after surgery 4. Intraoperative adverse events (vascular damage / organ damage / reconstruction / other) 5. Postoperative recovery (postoperative hospital stay, time to first flatus, time to first oral intake) 6. Surgical results (blood loss, operative time, console time, harvested lymph node number, R0 rese ction rate) | — |
Contacts
Public ContactNorikazu Yamada
Kansai Medical University Hospital
Outcome results
None listed